Related Experiment Video
Updated: Mar 22, 2026
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
Diffusion of Pharmacy-Based Influenza Vaccination Over Time in the United States
Grace J Chun1, Jessica M Sautter1, Brandon J Patterson1
1Grace J. Chun is a PharmD Candidate in the Department of Pharmacy Practice and Administration, University of the Sciences in Philadelphia, Philadelphia, PA. Jessica M. Sautter is with the Department of Behavioral and Social Sciences, University of the Sciences in Philadelphia. At the time of the study, Brandon J. Patterson and William F. McGhan were with the Department of Pharmacy Practice and Administration, University of the Sciences in Philadelphia.
Objectives:
To examine pharmacy-based influenza vaccination using diffusion of innovation theory.
Methods:
We used 1993 to 2013 Behavioral Risk Factor Surveillance System data to generate weighted prevalence rates of influenza vaccination, stratified by age (18-64 years vs ≥ 65 years) and state of residence. The diffusion of innovation theory adopter categories were residents of states allowing pharmacist vaccination before 1996 ("innovator/early adopters"), between 1996 and 1998 ("early majority"), between 1999 and 2004 ("late majority"), and in 2007 or later ("laggards").
Results:
For adults aged 18 to 64 years, vaccination rates were similar before the innovation (1993), diverged as the innovation reached the majority (2003), and were significantly lower for laggard states by 2013. Younger adults' vaccination rates steadily increased from 12% to 16% in 1993 to 29% to 36% in 2013. For older adults, there was no significant difference in vaccination rates between adopter categories in any year and no advantage associated with adoption category.
Conclusions:
Key features of pharmacy-based vaccination, including relative advantage and compatibility, are most relevant to younger adults; different interventions are warranted for older adults.
Related Concept Videos
01:51Vaccinations
01:27Influenza
01:28IV Infusion to Oral Dosing: Conversion Methods
01:26Pharmaceutical Poisoning: Potential Scenarios
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...